Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge urinary incontinence. This implantable tibial neuromodulation (ITNM) device ...

Under this partnership, the Minze Diary Pod – an automated bladder diary solution – will be offered as part of the SNM care pathway, enabling clinicians and patients to gather richer, more objective ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

Medtronic said it has won an FDA nod for an implantable tibial neuromodulation therapy that treats urge urinary incontinence. The Altaviva device is inserted near the ankle. The Dublin-based company ...

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ankle designed to be more convenient and accessible. Compared to other ...

To make life easier for people with a common bladder condition, Medtronic is digging in far away from urinary tract. Treatment for urinary urge incontinence can require pads, absorbent underwear and ...